Ever Source Wealth Advisors, LLC Vaxcyte, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.25 Billion
- Q1 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 19 shares of PCVX stock, worth $1,478. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 194
90.21%
Holding current value
$1,478
Previous $13,000
92.31%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PCVX
# of Institutions
268Shares Held
97.1MCall Options Held
202KPut Options Held
147K-
Vanguard Group Inc Valley Forge, PA9.74MShares$757 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.51MShares$740 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.67MShares$597 Million0.29% of portfolio
-
Wellington Management Group LLP Boston, MA4.92MShares$383 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.14MShares$322 Million0.07% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.61B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...